Skip to main content
HomeInvestors hubShareholder information


Shareholders


Investor news

PRESS-RELEASE
Asieris: Cevira (APL-1702) NDA Advances to Second Round of Technical Review
Oslo, Norway
4 August 2025
OSE Notice
Photocure ASA: Results for the second quarter of 2025
Oslo, Norway
30 July 2025
PRESS-RELEASE
Photocure ASA: Invitation to presentation of second quarter and first half year 2025 financial results
Oslo, Norway
22 July 2025
NEWS POST
Photocure starts up commercial operations in Spain
Oslo, Norway
26 June 2025
NEWS POST
New publication: Higher level of use of BLC improves bladder cancer patient outcomes
Oslo, Norway
25 June 2025
OSE Notice
Photocure ASA - Share option grant
Oslo, Norway
23 June 2025
NEWS POST
Asieris will present Cevira trial data and showcase Hexvix at the IPA congress
Oslo, Norway
6 June 2025
OSE Notice
Photocure ASA: Results for the first quarter of 2025
Oslo, Norway
8 May 2025
OSE Notice
Photocure ASA: Annual general meeting held
Oslo, Norway
5 May 2025
PRESS-RELEASE
Photocure ASA: Invitation to presentation of first quarter 2025 financial results
Oslo, Norway
30 April 2025
PRESS-RELEASE
Bladder Cancer presentations at AUA2025: Blue Light Cystoscopy improves risk stratification and informed decision making
Oslo, Norway
29 April 2025
OSE Notice
Photocure ASA - Notice of the Annual General Meeting 5 May 2025
Oslo, Norway
11 April 2025
OSE Notice
Photocure ASA: Annual Report 2024
Oslo, Norway
11 April 2025
OSE Notice
Photocure ASA: Transactions made under share buyback program
Oslo, Norway
2 April 2025
OSE Notice
Photocure ASA: Transactions made under share buyback program
Oslo, Norway
31 March 2025
OSE Notice
Photocure ASA - Share option grant to Vice President and General Manager EMEA
Oslo, Norway
26 March 2025